Inclusion of nonrandomized studies of interventions in systematic reviews of interventions: updated guidance from the Agency for Health Care Research and Quality Effective Health Care program
- PMID: 36245131
- PMCID: PMC10777810
- DOI: 10.1016/j.jclinepi.2022.08.015
Inclusion of nonrandomized studies of interventions in systematic reviews of interventions: updated guidance from the Agency for Health Care Research and Quality Effective Health Care program
Abstract
Objectives: We developed guidance to inform decisions regarding the inclusion of nonrandomized studies of interventions (NRSIs) in systematic reviews (SRs) of the effects of interventions.
Study design and setting: The guidance workgroup comprised SR experts and used an informal consensus generation method.
Results: Instead of recommending NRSI inclusion only if randomized controlled trials (RCTs) are insufficient to address the SR key question, different topics may require different decisions regarding NRSI inclusion. We identified important considerations to inform such decisions from topic refinement through protocol development. During topic scoping and refinement, considerations were related to the clinical decisional dilemma, adequacy of RCTs to address the key questions, risk of bias in NRSIs, and the extent to which NRSIs are likely to complement RCTs. When NRSIs are included, during SR team formation, familiarity with topic-specific data sources and advanced analytic methods for NRSIs should be considered. During protocol development, the decision regarding NRSI inclusion or exclusion should be justified, and potential implications explained. When NRSIs are included, the protocol should describe the processes for synthesizing evidence from RCTs and NRSIs and determining the overall strength of evidence.
Conclusion: We identified specific considerations for decisions regarding NRSI inclusion in SRs and highlight the importance of flexibility and transparency.
Keywords: Effectiveness; Guidance; Interventions; Nonrandomized studies; Study eligibility; Systematic reviews.
Copyright © 2022 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest: The authors have no conflicts of interest to disclose.
Disclosure: The authors have no relevant financial relationships to disclose.
Similar articles
-
Inclusion of Nonrandomized Studies of Interventions in Systematic Reviews of Intervention Effectiveness: An Update [Internet].Rockville (MD): Agency for Healthcare Research and Quality (US); 2022 Sep. Report No.: 22-EHC033. Rockville (MD): Agency for Healthcare Research and Quality (US); 2022 Sep. Report No.: 22-EHC033. PMID: 36153934 Free Books & Documents. Review.
-
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.Cochrane Database Syst Rev. 2020 Jul 10;7(7):CD013600. doi: 10.1002/14651858.CD013600.pub2. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2020 Oct 12;10:CD013600. doi: 10.1002/14651858.CD013600.pub3. PMID: 32648959 Free PMC article. Updated.
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Antidepressants for people with epilepsy and depression.Cochrane Database Syst Rev. 2021 Apr 16;4(4):CD010682. doi: 10.1002/14651858.CD010682.pub3. Cochrane Database Syst Rev. 2021. PMID: 33860531 Free PMC article.
-
Rituximab for people with multiple sclerosis.Cochrane Database Syst Rev. 2021 Nov 8;11(11):CD013874. doi: 10.1002/14651858.CD013874.pub2. Cochrane Database Syst Rev. 2021. PMID: 34748215 Free PMC article. Review.
Cited by
-
The reporting quality of meta-epidemiological studies needs substantial improvement: a research on research study.Syst Rev. 2024 Sep 28;13(1):244. doi: 10.1186/s13643-024-02661-7. Syst Rev. 2024. PMID: 39342302 Free PMC article.
-
Integrating randomized controlled trials and non-randomized studies of interventions to assess the effect of rare events: a Bayesian re-analysis of two meta-analyses.BMC Med Res Methodol. 2024 Sep 27;24(1):219. doi: 10.1186/s12874-024-02347-7. BMC Med Res Methodol. 2024. PMID: 39333867 Free PMC article.
-
Impact of Cognitive Behavior Therapy on Sexual Dysfunction of Women in Reproductive Age: A Systematic Review.Int J Sex Health. 2024 Jun 3;36(3):287-301. doi: 10.1080/19317611.2024.2360731. eCollection 2024. Int J Sex Health. 2024. PMID: 39148917
-
Evaluating the impact of including non-randomised studies of interventions in meta-analysis of randomised controlled trials: a protocol for a meta-epidemiological study.BMJ Open. 2023 Jul 26;13(7):e073232. doi: 10.1136/bmjopen-2023-073232. BMJ Open. 2023. PMID: 37495391 Free PMC article. Clinical Trial.
References
-
- Deeks JJ, Dinnes J, D’Amico R, Sowden AJ, Sakarovitch C, Song F, et al. Evaluating non-randomised intervention studies. Health Technol Assess 2003;7:1–173. iii-x. - PubMed
-
- Hernán MA, Hernández-Díaz S, Robins JM. A structural approach to selection bias. Epidemiology 2004;15:615–25. - PubMed
-
- Saldanha IJ, Skelly AC, Ley KV, Wang Z, Berliner E, Bass EB, et al. Inclusion of non-randomized studies of interventions in systematic reviews of intervention effectiveness: an update. Rockville (MD): Agency for Healthcare Research and Quality (US); 2022. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
